Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Creatinine before a contrast CT (iodinated contrast) or a gadolinium-enhanced MRI

Nephrology · Symptom or situation · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: In France in 2022, diagnostic imaging amounted to 1 083 procedures per 1 000 beneficiaries of the national health insurance, of which 15.6% were CT scans (CT frequency up about 11% since 2017); the share of contrast-enhanced CT is not given [1].

Before a test with iodinated contrast (CT, angiography)

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

After iodinated contrast in an at-risk patient

48 hours after the injection

Detailed explanation and international comparison (in French): read it in English (machine translation)

Before a gadolinium-enhanced MRI

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (9)
  1. Michel C, Sage J (ASNR). Exposition de la population aux rayonnements ionisants due aux actes d'imagerie médicale diagnostique réalisés en France en 2022 – étude ExPRI 2022. Résumé, Congrès national de radioprotection SFRP, La Baule, 17-19 juin 2025.
  2. Société française de radiologie (SFR), Comité interdisciplinaire de recherche et de travail sur les agents de contraste en imagerie (CIRTACI). Fiche de recommandation pour la pratique clinique : rein et produits de contraste. Version 2.4, décembre 2020 (validée par la Société francophone de néphrologie, dialyse et transplantation).
  3. European Society of Urogenital Radiology (ESUR), Contrast Media Safety Committee. ESUR Guidelines on Contrast Agents, version 10.0, 2018 ; sections A.3.2, B.1 à B.4 et « Non-emergency biochemical assays ».
  4. ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit GLUCOPHAGE 1000 mg (metformine), rubriques 4.3, 4.4 et 4.5, page mise à jour le 29 septembre 2026, consultée le 11 octobre 2026.
  5. Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med. 2020;2(1):85-93.
  6. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Section 4: Contrast-induced AKI. Kidney Int Suppl. 2012;2(1):69-88.
  7. National Institute for Health and Care Excellence (NICE). Acute kidney injury: prevention, detection and management. NICE guideline NG148, publiée le 18 décembre 2019, mise à jour le 16 octobre 2024.
  8. American College of Radiology (ACR), Committee on Drugs and Contrast Media. ACR Manual on Contrast Media 2026 (chapitres « Post-Contrast Acute Kidney Injury and Contrast-Induced Nephropathy in Adults » et « Nephrogenic Systemic Fibrosis », mise à jour 2025).
  9. Kidney Health Australia. Chronic Kidney Disease (CKD) Management in Primary Care. 5e édition. Melbourne : Kidney Health Australia ; 2024 (manuel destiné à la médecine générale).